Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2018

May 9, 2018

30198_dirs_2018-05-09_1acc0609-0860-49ea-8791-fe1831ca55f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-05-08

Reporting Person: SKYLER JAY S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-08 Common Stock M 31464 $7.63 Acquired 53721 Indirect
2018-05-08 Common Stock S 31464 $85.1139 Disposed 22257 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-08 Non-Qualified Stock Option (right to buy) $7.63 M 31464 Disposed 2018-05-19 Common Stock (31464) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4553 Direct
Common Stock 10000 Indirect

Footnotes

F1: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.

F2: This transaction was executed in multiple trades at prices ranging from $84.85 to $85.52. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.